Publicacións nas que colabora con David García García (14)

2019

  1. Parkinson’s disease with mild cognitive impairment: severe cortical thinning antedates dementia

    Brain Imaging and Behavior, Vol. 13, Núm. 1, pp. 180-188

2016

  1. Significance of visual hallucinations and cerebral hypometabolism in the risk of dementia in Parkinson's disease patients with mild cognitive impairment

    Human Brain Mapping, Vol. 37, Núm. 3, pp. 968-977

  2. Stimulation sites in the subthalamic nucleus and clinical improvement in Parkinson's disease: A new approach for active contact localization

    Journal of Neurosurgery, Vol. 125, Núm. 5, pp. 1068-1079

2015

  1. The Relationship Between Atrophy and Hypometabolism: Is It Regionally Dependent in Dementias?

    Current Neurology and Neuroscience Reports, Vol. 15, Núm. 7

2014

  1. Grey matter hypometabolism and atrophy in Parkinson's disease with cognitive impairment: A two-step process

    Brain, Vol. 137, Núm. 8, pp. 2356-2367

  2. High beta activity in the subthalamic nucleus and freezing of gait in Parkinson's disease

    Neurobiology of Disease, Vol. 64, pp. 60-65

2013

  1. The subthalamic nucleus is involved in successful inhibition in the stop-signal task: A local field potential study in Parkinson's disease

    Experimental Neurology, Vol. 239, Núm. 1, pp. 1-12

2012

  1. Posterior parietooccipital hypometabolism may differentiate mild cognitive impairment from dementia in Parkinson's disease

    European Journal of Nuclear Medicine and Molecular Imaging, Vol. 39, Núm. 11, pp. 1767-1777

  2. The impact of silent vascular brain burden in cognitive impairment in Parkinson's disease

    European Journal of Neurology, Vol. 19, Núm. 8, pp. 1100-1107

2011

  1. Functional bold MRI: Advantages of the 3 T vs. the 1.5 T

    Clinical Imaging, Vol. 35, Núm. 3, pp. 236-241

  2. Involvement of the subthalamic nucleus in impulse control disorders associated with Parkinson's disease

    Brain, Vol. 134, Núm. 1, pp. 36-49

2010

  1. Progression of dopaminergic depletion in a model of MPTP-induced Parkinsonism in non-human primates. An 18F-DOPA and 11C-DTBZ PET study

    Neurobiology of Disease, Vol. 38, Núm. 3, pp. 456-463

2009

  1. Homocysteine and cognitive impairment in Parkinson's disease: A biochemical, neuroimaging, and genetic study

    Movement Disorders, Vol. 24, Núm. 10, pp. 1437-1444

2008

  1. Neuronal activity of the red nucleus in Parkinson's disease

    Movement Disorders, Vol. 23, Núm. 6, pp. 908-911